Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Butt

Showing results (601-610 of 661) with videos related to

Pageof 67
Sort By:
Influenza and Other Respiratory Viruses|September 29, 2024
BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Frontiers in Medicine|March 26, 2024
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimationHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Elife|June 9, 2025
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Surgical Oncology|January 22, 2026
The rate of non-sentinel lymph node metastases at axillary dissection in patients with a positive sentinel lymph node after neoadjuvant chemotherapyA M Zaborowski, F Wehrmann, J McGarry, et al.
Scientific Reports|October 8, 2025
Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMC Infectious Diseases|August 17, 2025
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide studyHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Journal of Travel Medicine|April 9, 2024
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variantHiam Chemaitelly, Peter Coyle, Mohamed Ali Ben Kacem, et al.
Gastroenterology|April 2, 2013
Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA RegistryRehan J Haidry, Jason M Dunn, Mohammed A Butt, et al.
Open Forum Infectious Diseases|March 17, 2025
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Eclinicalmedicine|May 3, 2021
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyLaith J Abu-Raddad, Hiam Chemaitelly, Peter Coyle, et al.
Pageof 67

Showing results (601-610 of 661) with videos related to

Sort By:
Pageof 67
Influenza and Other Respiratory Viruses|September 29, 2024
BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Frontiers in Medicine|March 26, 2024
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimationHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Elife|June 9, 2025
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Surgical Oncology|January 22, 2026
The rate of non-sentinel lymph node metastases at axillary dissection in patients with a positive sentinel lymph node after neoadjuvant chemotherapyA M Zaborowski, F Wehrmann, J McGarry, et al.
Scientific Reports|October 8, 2025
Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMC Infectious Diseases|August 17, 2025
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide studyHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Journal of Travel Medicine|April 9, 2024
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variantHiam Chemaitelly, Peter Coyle, Mohamed Ali Ben Kacem, et al.
Gastroenterology|April 2, 2013
Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA RegistryRehan J Haidry, Jason M Dunn, Mohammed A Butt, et al.
Open Forum Infectious Diseases|March 17, 2025
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Eclinicalmedicine|May 3, 2021
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyLaith J Abu-Raddad, Hiam Chemaitelly, Peter Coyle, et al.
Pageof 67